TEL AVIV, Israel, February 3, 2014 /PRNewswire/ --
The Trendlines Group announced today that during 2013, our portfolio companies raised ~$20 million. Among these companies were LapSpace, Leviticus Cardio and MitrAssist. As well, ApiFix completed its second funding round. Last year marked the first time our companies received investments from Chinese investors. Since 2007, our portfolio companies have raised $140 million (not including government funding).
With our entrepreneur partners, we created 9 new companies in 2013. On the agritech side, BioFishency, FuturaGraft, Metabolic Robots, Saturas, and Valentis started up. And in medical, we established Arch2Fix, Omeq Medical, STS Medical, and VisiDome. Since 2007, Trendlines has started 52 medical and agricultural technology companies. Our portfolio now numbers 55, including 15 revenue-stage companies.
Awards & Recognition
Israel's Office of the Chief Scientist named ApiFix and Sol Chip "Best Start-Ups." Sol Chip also received the award for Best Technical Development of Energy Harvesting at IDTechEx 2013 IDTechEx.
GreenSpense walked away with two awards from the 2013 International Cleantech Open Ideas Competition in California: 1st place in the Chemistry & Advanced Materials Global Ideas category and 2nd place overall. Closer to home, Mem-Tech's founders, Prof. Raphael Semiat and Prof. Moris Eisen, were awarded the prestigious Innovative Applied Engineering Research prize by the Board of Governors of the Technion-Israel Institute of Technology.
A Dynamic Year for Trendlines Corporate
The year in review wouldn't be complete without mentioning events and conferences, from our 3rd Annual Investment Event in Israel that started the year off to our 2nd Annual Agrivest, an extraordinary finish. Experts from Bayer, Syngenta, Monsanto, PepsiCo traveled to Israel to participate in one of the panel discussions at Agrivest.
In between, we organized three U.S. Road Shows, and addressed two conferences in China. For more highlights, visit http://www.trendlines.com
Ofir Shpigel Media and Public Relations
SOURCE The Trendlines Group